SG171602A1 - Use of antisecretory factors for treating intraocular hypertension - Google Patents

Use of antisecretory factors for treating intraocular hypertension

Info

Publication number: SG171602A1
Authority: SG; Singapore
Prior art keywords: antisecretory; intraocular hypertension; antisecretory factors; factors; prevention
Prior art date: 2006-04-27

Application number

SG201102876-8A

Other languages

English (en)

Inventor

Hans-Arne Hansson

Stefan Lange

Eva Jennische

Original Assignee

Lantmaennen As Faktor Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-04-27

Filing date

2007-04-27

Publication date

2011-06-29

2007-04-27 Application filed by Lantmaennen As Faktor Ab filed Critical Lantmaennen As Faktor Ab

2011-06-29 Publication of SG171602A1 publication Critical patent/SG171602A1/en

Links

230000001262 anti-secretory effect Effects 0.000 title abstract 5
206010020772 Hypertension Diseases 0.000 title abstract 3
239000008194 pharmaceutical composition Substances 0.000 abstract 2
230000002265 prevention Effects 0.000 abstract 2
210000001124 body fluid Anatomy 0.000 abstract 1
239000010839 body fluid Substances 0.000 abstract 1
239000012634 fragment Substances 0.000 abstract 1
230000004410 intraocular pressure Effects 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Ophthalmology & Optometry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Marine Sciences & Fisheries (AREA)
Zoology (AREA)
Dispersion Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)

SG201102876-8A 2006-04-27 2007-04-27 Use of antisecretory factors for treating intraocular hypertension SG171602A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE0600932		2006-04-27

Publications (1)

Publication Number	Publication Date
SG171602A1 true SG171602A1 (en)	2011-06-29

Family

ID=38561776

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG201102876-8A SG171602A1 (en)	2006-04-27	2007-04-27	Use of antisecretory factors for treating intraocular hypertension

Country Status (18)

Country	Link
US (2)	US8207296B2 (pl)
EP (2)	EP2015767B1 (pl)
JP (2)	JP5284948B2 (pl)
KR (1)	KR20090040404A (pl)
CN (2)	CN102633863B (pl)
AU (1)	AU2007244004B2 (pl)
BR (1)	BRPI0710959B8 (pl)
CA (2)	CA2771087C (pl)
DK (2)	DK2015767T3 (pl)
ES (2)	ES2561945T3 (pl)
IL (1)	IL194773A (pl)
MX (1)	MX2008013769A (pl)
NZ (2)	NZ572255A (pl)
PL (2)	PL2015767T3 (pl)
RU (1)	RU2458703C2 (pl)
SG (1)	SG171602A1 (pl)
WO (1)	WO2007126364A2 (pl)
ZA (1)	ZA200809115B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL2015767T3 (pl) *	2006-04-27	2016-05-31	Lantmaennen As Faktor Ab	Zastosowanie czynnika przeciwwydzielniczego do leczenia nadciśnienia śródgałkowego
US9962424B2 (en)	2007-04-27	2018-05-08	Lantmännen As-Faktor Ab	Use of antisecretory factors (AF) for optimizing cellular uptake
EP3769778A1 (en)	2009-02-11	2021-01-27	Lantmännen Medical AB	Use of antisecretory factors (af) for optimizing cellular uptake
WO2013050795A1 (en) *	2011-10-03	2013-04-11	Femtonics Kft.	Use of photoactive compounds
US20190192622A1 (en) *	2012-12-20	2019-06-27	Lantmännen As-Faktor Ab	Use of Antisecretory Factor (AF) in Glioblastoma Treatment
WO2017009004A1 (en) *	2015-07-10	2017-01-19	Lantmännen As-Faktor Ab	Process for producing egg yolk with high content of af-16
WO2018015379A1 (en)	2016-07-18	2018-01-25	Lantmännen As-Faktor Ab	Antisecretory factor 17
US12582697B2 (en)	2018-06-28	2026-03-24	Lantmännen Medical Ab	Antisecretory factor for use in treatment and/or prevention of acute respiratory failure
WO2020065089A2 (en)	2018-09-28	2020-04-02	Lantmännen Functional Foods Ab	A consumable product comprising malted dehulled oat
WO2020065091A1 (en)	2018-09-28	2020-04-02	Lantmännen Functional Foods Ab	A consumable product comprising malted wheat
US20230096303A1 (en)	2020-03-26	2023-03-30	Lantmännen Functional Foods Ab	A Consumable Product Comprising Malted Cereals for Promoting Recovery at Physical Activity
US20240148709A1 (en) *	2022-11-08	2024-05-09	Aisa Pharma, Inc.	Methods of treating eye pain and eye disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH682716A5 (de)	1992-01-13	1993-11-15	Christian Fricker	Benzo-Pyrone und/oder Dobesilat-Calcium enthaltende pharmazeutische Zusammensetzung.
US5585401A (en) *	1994-12-09	1996-12-17	The Reents Of The University Of California	Method for enhancing outflow of aqueous humor in treatment of glaucoma
SE508609C2 (sv)	1995-08-24	1998-10-19	Rural Patent Svenska Ab	Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning
JP2000506375A (ja) *	1996-01-26	2000-05-30	エイチエスシーリサーチアンドデベロップメントリミテッドパートナーシップ	アルツハイマー病に関連する核酸およびタンパク質、ならびにその使用
SE9604251L (sv)	1996-11-20	1997-12-22	Svenska Lantmaennen Riksfoerbu	Födoämne som vid förtäring inducerar antisekretoriska proteiner
SE513496C2 (sv)	1998-12-17	2000-09-18	Rural Patent Svenska Ab	NASP-berikad äggula samt dess användning
WO2001005968A1 (en) *	1999-06-21	2001-01-25	Inkine Pharmaceutical Company, Inc.	Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor
RU2192898C1 (ru) *	2001-08-16	2002-11-20	Московский научно-исследовательский институт глазных болезней им. Гельмгольца	Способ лечения герпетического кератита с изъязвлением
GB0322645D0 (en) *	2003-09-26	2003-10-29	Melacure Therapeutics Ab	Use of antisecretory factor peptides
ES2472737T3 (es) *	2006-04-27	2014-07-02	Lantmnnen As-Faktor Ab	Usos m�dicos adicionales de la proteína antisecretora
EP2037950B1 (en) *	2006-04-27	2014-04-23	Lantmännen AS-Faktor AB	Further medical uses of antisecretory protein
PL2015767T3 (pl) *	2006-04-27	2016-05-31	Lantmaennen As Faktor Ab	Zastosowanie czynnika przeciwwydzielniczego do leczenia nadciśnienia śródgałkowego

2007
- 2007-04-27 PL PL07748079T patent/PL2015767T3/pl unknown
- 2007-04-27 RU RU2008146733/15A patent/RU2458703C2/ru active
- 2007-04-27 MX MX2008013769A patent/MX2008013769A/es active IP Right Grant
- 2007-04-27 CA CA2771087A patent/CA2771087C/en not_active Expired - Fee Related
- 2007-04-27 ES ES07748079.6T patent/ES2561945T3/es active Active
- 2007-04-27 NZ NZ572255A patent/NZ572255A/en not_active IP Right Cessation
- 2007-04-27 DK DK07748079.6T patent/DK2015767T3/en active
- 2007-04-27 JP JP2009507632A patent/JP5284948B2/ja not_active Expired - Fee Related
- 2007-04-27 CA CA2650344A patent/CA2650344C/en not_active Expired - Fee Related
- 2007-04-27 SG SG201102876-8A patent/SG171602A1/en unknown
- 2007-04-27 WO PCT/SE2007/000414 patent/WO2007126364A2/en not_active Ceased
- 2007-04-27 PL PL12157100T patent/PL2468292T3/pl unknown
- 2007-04-27 ES ES12157100T patent/ES2773945T3/es active Active
- 2007-04-27 BR BRPI0710959A patent/BRPI0710959B8/pt not_active IP Right Cessation
- 2007-04-27 CN CN201210058790.XA patent/CN102633863B/zh not_active Expired - Fee Related
- 2007-04-27 EP EP07748079.6A patent/EP2015767B1/en not_active Not-in-force
- 2007-04-27 DK DK12157100.4T patent/DK2468292T3/da active
- 2007-04-27 NZ NZ598426A patent/NZ598426A/xx not_active IP Right Cessation
- 2007-04-27 CN CN200780014996.XA patent/CN101432013B/zh not_active Expired - Fee Related
- 2007-04-27 AU AU2007244004A patent/AU2007244004B2/en not_active Ceased
- 2007-04-27 KR KR1020087029053A patent/KR20090040404A/ko not_active Ceased
- 2007-04-27 EP EP12157100.4A patent/EP2468292B8/en active Active
2008
- 2008-10-22 IL IL194773A patent/IL194773A/en active IP Right Grant
- 2008-10-23 ZA ZA200809115A patent/ZA200809115B/xx unknown
- 2008-10-27 US US12/289,388 patent/US8207296B2/en not_active Expired - Fee Related
2012
- 2012-03-05 JP JP2012047547A patent/JP2012153695A/ja active Pending
- 2012-05-11 US US13/469,838 patent/US9000125B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU2007244004A1 (en)	2007-11-08
CA2650344A1 (en)	2007-11-08
JP2012153695A (ja)	2012-08-16
US8207296B2 (en)	2012-06-26
CA2771087A1 (en)	2007-11-08
ES2773945T3 (es)	2020-07-15
WO2007126364A2 (en)	2007-11-08
CN102633863B (zh)	2014-08-06
DK2468292T3 (da)	2020-03-23
CA2650344C (en)	2017-10-31
MX2008013769A (es)	2009-02-03
EP2015767B1 (en)	2016-01-06
RU2008146733A (ru)	2010-06-10
BRPI0710959A2 (pt)	2012-02-28
IL194773A (en)	2015-07-30
DK2015767T3 (en)	2016-02-08
PL2015767T3 (pl)	2016-05-31
CN101432013B (zh)	2015-01-07
ES2561945T3 (es)	2016-03-01
AU2007244004B2 (en)	2012-02-09
KR20090040404A (ko)	2009-04-24
PL2468292T3 (pl)	2020-08-24
BRPI0710959B8 (pt)	2021-05-25
WO2007126364A8 (en)	2009-07-23
US20090162296A1 (en)	2009-06-25
US9000125B2 (en)	2015-04-07
JP5284948B2 (ja)	2013-09-11
CA2771087C (en)	2016-03-15
EP2468292A1 (en)	2012-06-27
BRPI0710959B1 (pt)	2018-11-06
WO2007126364A3 (en)	2008-03-06
US20120283191A1 (en)	2012-11-08
EP2468292B1 (en)	2019-12-18
NZ572255A (en)	2012-03-30
EP2015767A2 (en)	2009-01-21
EP2468292B8 (en)	2020-02-26
CN102633863A (zh)	2012-08-15
NZ598426A (en)	2012-08-31
JP2009535329A (ja)	2009-10-01
ZA200809115B (en)	2009-07-29
IL194773A0 (en)	2011-08-01
RU2458703C2 (ru)	2012-08-20
CN101432013A (zh)	2009-05-13

Publication	Publication Date	Title
SG171602A1 (en)	2011-06-29	Use of antisecretory factors for treating intraocular hypertension
WO2007076360A8 (en)	2007-12-06	(indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)- pyrazines for treating rho kinase-mediated diseases and conditions
WO2006071548A3 (en)	2006-09-08	Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases
WO2003092584A3 (en)	2004-07-01	Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
WO2009047766A3 (en)	2010-03-11	Composition and method for the treatment or prevention of glaucoma and ocular hypertension
WO2007035356A3 (en)	2007-12-27	Glaucoma treatment devices and methods
WO2007104541A3 (en)	2008-06-26	Compositions and methods using serine protease inhibiting peptides for treating ophthalmic disorders
WO2006124874A3 (en)	2007-04-05	Inhibitors of b-raf kinase
MX2009001062A (es)	2009-02-06	Agonistas de ep2.
WO2005002520A3 (en)	2005-03-31	Ophthalmic compositions for treating ocular hypertension
WO2007108968A3 (en)	2007-11-29	Ophthalmic compositions for treating ocular hypertension
MX2010014233A (es)	2011-03-25	Compuestos quimicos 251.
WO2008057458A3 (en)	2008-11-27	Antagonists of pcsk9
WO2007016538A3 (en)	2007-10-04	Preparation and use of biphenyl amino acid derivatives for the treatment of obesity
MX2010007295A (es)	2010-10-11	Composiciones acuosas estables de ciclosporina.
MY150250A (en)	2013-12-31	Ketorolac tromethamine compositions for treating or preventing ocular pain
WO2004069181A3 (en)	2005-02-24	Composition for the treatment of intraocular pressure
MY138811A (en)	2009-07-31	Preventive or therapeutic agent for glaucoma
WO2006044425A3 (en)	2006-06-15	Ophthalmic compositions for treating ocular hypertension
WO2004043354A3 (en)	2004-08-26	Ophthalmic compositions for treating ocular hypertension
WO2007127711A3 (en)	2008-03-27	Abnormal cannabidiols as agents for lowering intraocular pressure
WO2007022947A3 (de)	2007-05-03	5-ring-heteroaromaten-verbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren
WO2007146136A3 (en)	2008-06-19	Ophthalmic compositions for treating ocular hypertension
BR0316775A (pt)	2005-11-01	Novos análogos de benzopirano e seu uso para o tratamento de glaucoma
MX2009004792A (es)	2009-05-21	Moduladores de la union de pai-1 para el tratamiento de trastornos oculares.